Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia.
about
A Role for the Intestinal Microbiota and Virome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)?Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristicsThe emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs).Chronic fatigue syndrome and complement activation.Three Adult Cases of HPV-B19 Infection with Concomitant Leukopenia and Low Platelet Counts.Characterization of Markers of the Progression of Human Parvovirus B19 Infection in Virus DNA-Positive Plasma SamplesAssociation of active human herpesvirus-6, -7 and parvovirus b19 infection with clinical outcomes in patients with myalgic encephalomyelitis/chronic fatigue syndrome.Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue.Programmed symptoms: disparate effects united by purpose.Oxidative and Nitrosative Stress and Immune-Inflammatory Pathways in Patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability.The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease.Pericarditis and pleuritis associated with human parvovirus B19 infection in a systemic lupus erythematosus patient.Recipients potentially infected with parvovirus B19 by red blood cell products.Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model.Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
P2860
Q26747503-5E3C4CD2-0F91-48C3-8816-1E4242420B67Q26998412-899ECCA8-7ED4-4DBE-9761-11E709AA7BF6Q34373452-8C673109-E2BD-40B9-A2BC-61F12CDB89BEQ34525946-DD5A8B09-58F3-4F52-85A1-75CB6A1B3847Q35135919-0BD03595-E55F-4560-855A-1F0F884D5422Q36058219-78062C8A-A27A-4902-9A8A-41E92B249465Q36184537-E8383F41-6403-40B2-9F1D-60329A14AB29Q36346397-5DCB698A-785D-4DBA-AC2C-E026DF050EE6Q37204042-4EB08B40-E729-4FEB-9598-5F13D03C754CQ37661367-AC19C65C-E445-4F51-9B3E-49E842C050A0Q38529622-B6A103FB-4B40-4D12-AF23-F8B906E1A744Q38661867-20802392-A225-4628-A3D1-D30C42126C4AQ40354470-6A1C6874-7F68-4971-8E74-97B67365B6ECQ44099707-0DDF3F14-4A02-4AF4-A16E-C91FFAAE29E7Q50333926-F861E003-9127-445E-B1C4-5DB9DA9B508AQ55387468-98038071-A6D9-4D70-8E71-C69369CF517B
P2860
Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia.
@ast
Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia.
@en
Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia.
@nl
type
label
Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia.
@ast
Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia.
@en
Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia.
@nl
prefLabel
Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia.
@ast
Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia.
@en
Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia.
@nl
P2093
P356
P1433
P1476
Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia.
@en
P2093
Chikako Arakawa
Mariko Seishima
Yoko Mizutani
Yoshinao Shibuya
P2860
P304
P356
10.1159/000116723
P577
2008-02-15T00:00:00Z